Taro-Lenalidomide 25 mg (Lenalidomide CAPSULE) 25 MG

TARO-LENALIDOMIDE 25 MG capsules are a prescription medication used to manage certain conditions. This oral treatment is designed to support therapeutic outcomes in specific medical scenarios.

Strength

25 MG

Manufacturer / TM Owner

TARO PHARMACEUTICALS INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

TARO-LENALIDOMIDE 25 MG capsules are primarily used in the management of conditions that require immunomodulatory therapy. This medication is often prescribed for its potential to support the body's immune response. Patients may wonder, 'What is lenalidomide used for?' Typically, it is utilized in the treatment of disorders that benefit from immune system modulation.

Side Effects

Common effects of TARO-LENALIDOMIDE 25 MG capsules may include fatigue, nausea, and constipation. Some users might experience dizziness or muscle cramps. It is important to note that individual responses can vary, and not everyone will experience these effects.

Precautions & Warnings

TARO-LENALIDOMIDE 25 MG capsules should be handled with care. Pregnant women should avoid contact with the medication due to potential risks. It is advisable to consult a healthcare provider before starting this treatment to discuss any pre-existing conditions or other medications being taken.

Avoid Interactions

TARO-LENALIDOMIDE 25 MG capsules may interact with certain medications, including those that affect the immune system. Alcohol consumption should be avoided as it may exacerbate side effects. Always inform your healthcare provider about all medications and supplements you are taking to prevent potential interactions.

Frequently Asked Questions

TARO-LENALIDOMIDE 25 MG capsules are used to manage conditions that require immunomodulatory therapy, supporting the body's immune response.

TARO-LENALIDOMIDE 25 MG capsules are taken orally, typically as prescribed by a healthcare provider.

Common side effects may include fatigue, nausea, constipation, dizziness, and muscle cramps.

Potential interactions may occur with medications that affect the immune system. Always consult a healthcare provider before combining medications.

Pregnant women should avoid contact with TARO-LENALIDOMIDE 25 MG due to potential risks.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.